Among tumor-infiltrating T lymphocytes, CD8+ T cells seemed to actively participate in the antitumor LNM response in patients with HNSCC, which was also identified through the Chi-squared analysis of the IHC scores of CD8 (p = 0.001). Here, CD8A is linked to neoplasm.